XRF ScientificASX:XRF 100 Return-on-Tangible-Equity is 24.27% as of Dec. 2025, which is 20% above its 10-year median of 20.26. GuruFocus rates ASX:XRF with a GF Score™ of 100/100 and a GF Value™ of A$1.65 (Fairly Valued). The stock has 1 warning sign investors should review. Among 547 Conglomerates companies, XRF Scientific ranks better than 85.74% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. XRF Scientific's annualized net income for the quarter that ended in Dec. 2025 was A$10.52 Mil. XRF Scientific's average shareholder tangible equity for the quarter that ended in Dec. 2025 was A$43.36 Mil. Therefore, XRF Scientific's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 24.27%.
The historical rank and industry rank for XRF Scientific's Return-on-Tangible-Equity or its related term are showing as below:
ASX:XRF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 5.29 Med: 20.26 Max: 26.09
Current: 25.8
During the past 13 years, XRF Scientific's highest Return-on-Tangible-Equity was 26.09%. The lowest was 5.29%. And the median was 20.26%.
ASX:XRF's Return-on-Tangible-Equity is ranked better than 85.74% of 547
companies
in the Conglomerates industry
Industry Median: 7.44
vs ASX:XRF: 25.80
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
XRF Scientific Return-on-Tangible-Equity Related Terms
XRF Scientific Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for XRF Scientific's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:XRF vs HON, MMM: Return-on-Tangible-Equity Comparison
For the Conglomerates subindustry, XRF Scientific's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific Return-on-Tangible-Equity vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where XRF Scientific's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 24.27% mean?
XRF Scientific (ASX:XRF) has a Return-on-Tangible-Equity of 24.27% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on XRF Scientific and its competitors. This is 20% above median its historical median of 20.26. Over the past decade, XRF Scientific's Return-on-Tangible-Equity has ranged from 5.29 to 26.09. According to the industry distribution chart, XRF Scientific ranks #78 out of 547 companies in the Conglomerates industry, placing it in the top 14.3%.
Is XRF Scientific's Return-on-Tangible-Equity too high?
XRF Scientific's current Return-on-Tangible-Equity of 24.27% is 20% above median its 10-year median of 20.26. Over the past 10 years, this metric has ranged from a low of 5.29 to a high of 26.09. The Conglomerates industry median Return-on-Tangible-Equity is 7.44. XRF Scientific's value of 24.27% is 226.2% above this industry median. Based on the distribution chart, XRF Scientific ranks #78 out of 547 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, XRF Scientific has a GF Score™ of 100/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's Return-on-Tangible-Equity compare to HON and MMM?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #78 out of 547 companies for Return-on-Tangible-Equity. This places XRF Scientific in the top 14% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 7.44. XRF Scientific's value of 24.27% is 226.2% above this benchmark. Historically, XRF Scientific's own Return-on-Tangible-Equity has ranged from 5.29 to 26.09 over the past decade. While the company's 10-year median is 20.26 vs. the industry median of 7.44, XRF Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Conglomerates company?
The median Return-on-Tangible-Equity among Conglomerates companies is 7.44, based on 547 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current Return-on-Tangible-Equity of 24.27% is 226.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on XRF Scientific and its competitors. For the Conglomerates industry, the median Return-on-Tangible-Equity is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current Return-on-Tangible-Equity is 24.27%, which is 20% above median its own 10-year median of 20.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.65, compared to a current price of A$1.73 — trading 4.5% above its estimated fair value. The current Return-on-Tangible-Equity is 24.27%, which is 20% above median its 10-year median of 20.26 and 226.2% above the Conglomerates industry median of 7.44. XRF Scientific's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current Return-on-Tangible-Equity is 24.27% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.73 is trading 4.5% above its estimated GF Value™ of A$1.65.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
Return-on-Tangible-Equity: 24.27% (20% above median its 10-year median of 20.26)
GF Value™: A$1.65 vs. price of A$1.73 (4.5% above fair value)
Industry Position: 226.2% above the Conglomerates median (#78 of 547)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
100GF Score
Get the complete analysis for ASX:XRF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
